MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RGNX has $341,894K in assets. $320,812K in debts. $15,229K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
262.29%
Quick Ratio
262.29%
Cash Ratio
21.42%
Debt to Asset Ratio
93.83%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Property and equipment, net
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty monetization liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
15,229 34,466 58,802 79,558
Marketable securities
135,262 195,604 215,403 243,740
Accounts receivable
10,038 26,379 25,347 20,199
Prepaid expenses
11,543 11,927 12,943 10,776
Other current assets
14,444 12,905 19,472 19,479
Total current assets
186,516 281,281 331,967 373,752
Marketable securities
-10,785 27,838 40,296
Accounts receivable
420 2,312 2,765 1,584
Total property and equipment
192,879 192,047 191,054 -
Accumulated depreciation and amortization
91,005 87,192 83,539 -
Property and equipment, net
101,874 104,855 107,515 111,017
Operating lease right-of-use assets
45,541 47,156 48,820 50,469
Restricted cash
2,030 2,030 2,030 2,030
Other assets
5,513 4,613 4,268 1,879
Total assets
341,894 453,032 525,203 581,027
Accounts payable
21,207 21,358 22,266 21,655
Accrued expenses and other current liabilities
21,892 38,390 38,316 35,557
Deferred revenue
5,919 10,452 13,195 13,977
Operating lease liabilities
7,867 8,286 9,073 8,049
Royalty monetization liabilities
14,225 39,609 41,718 40,302
Total current liabilities
71,110 118,095 124,568 119,540
Deferred revenue
22,776 18,943 21,186 23,804
Operating lease liabilities
63,199 65,215 67,433 69,647
Royalty monetization liabilities
163,105 147,408 149,916 153,693
Other liabilities
622 638 648 664
Total liabilities
320,812 350,299 363,751 367,348
Common stock 0.0001 par value 100,000 shares authorized at march 31, 2026 and december 31, 2025 51,617 and 50,892 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
5 5 5 5
Additional paid-in capital
1,238,025 1,229,442 1,220,977 1,211,361
Accumulated other comprehensive loss
-870 -687 -652 -750
Accumulated deficit
-1,216,078 -1,126,027 -1,058,878 -996,937
Total stockholders equity
21,082 102,733 161,452 213,679
Total liabilities and stockholders equity
341,894 453,032 525,203 581,027
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$135,262K Cash and cashequivalents$15,229K Other current assets$14,444K Prepaid expenses$11,543K Accounts receivable$10,038K Total property andequipment$192,879K Total current assets$186,516K Property and equipment,net$101,874K Operating leaseright-of-use assets$45,541K Other assets$5,513K Restricted cash$2,030K Accounts receivable$420K Accumulated depreciationand amortization$91,005K Total assets$341,894K Total liabilities andstockholders equity$341,894K Total liabilities$320,812K Total stockholdersequity$21,082K Accumulated deficit-$1,216,078K Accumulated othercomprehensive loss-$870K Royalty monetizationliabilities$163,105K Total currentliabilities$71,110K Operating leaseliabilities$63,199K Deferred revenue$22,776K Other liabilities$622K Additional paid-in capital$1,238,025K Common stock 0.0001 parvalue 100,000 shares...$5K Accrued expenses andother current...$21,892K Accounts payable$21,207K Royalty monetizationliabilities$14,225K Operating leaseliabilities$7,867K Deferred revenue$5,919K

REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX)